AVNS 241220 22.50C (AVNS241220C22500) Stock Options, News & Quotes

US OptionsDetailed Quotes

AVNS241220C22500

Watchlist

2.10
0.000.00%

15min DelayClose Nov 22 15:59 ET

0.00High0.00Low

Intraday

5D
Daily

News

Wall Street Set to Open Higher Wednesday as Investors Await Nvidia's Earnings, Jobless Data
MT NewswiresNov 20 09:11 ET
Avanos Medical Announced That The CMS Has Issued Its Final Medicare Hospital OPPS And Medicare ASC Payment System Rule For 2025; Effective Jan. 1, 2025, Implements The Non-Opioids Prevent Addiction In The Nation Act That Mandates Separate Medicare...
BenzingaNov 11 09:42 ET
ON-Q* Elastomeric Infusion Pump and AmbIT* Disposable Electronic Infusion Pump to Receive Separate Payment Under NOPAIN Act Starting January 1, 2025
PR NewswireNov 11 09:38 ET
Avanos Medical, Inc. to Present at the UBS Healthcare Conference 2024
PR NewswireNov 8 16:16 ET
We Think Avanos Medical's (NYSE:AVNS) Healthy Earnings Might Be Conservative
Yahoo FinanceNov 6 07:01 ET
Avanos Medical Launches New CORGRIP SR
PR NewswireNov 5 07:00 ET

Comments

Moomoo AI

Mar 17 09:40

Recent insider selling of Avanos Medical stock, particularly by Senior VP Michael Greiner, is concerning. Insiders' lack of significant ownership and their share selling could deter potential investors.

This Insider Has Just Sold Shares In Avanos Medical

Moomoo AI

Feb 23 09:12

Unresolved challenges may be indicated by weak growth and share price performance. The market's focus is likely on revenue due to the company's lack of profits. Accelerated revenue growth or profits could attract more interest in the stock.

The Past Five Years for Avanos Medical (NYSE:AVNS) Investors Has Not Been Profitable

Moomoo AI

Jan 5 06:57

Analysts predict a below-average future growth rate for Avanos Medical despite its high P/E ratio. This warns of a possible risk for investors, who might pay a premium not supported by the earnings outlook.

Earnings Not Telling The Story For Avanos Medical, Inc. (NYSE:AVNS)